← Back

Norrsken VC

Europe HQ Seed Series-A Above Series A
Cheque range
£1M – £15M
Stages
Seed, Series A, Above Series A
Avg deals / year
3.6
Leads rounds
Yes
HQ
Europe
Fund type
Venture fund

01 · Thesis & focus

Norrsken VC is a Stockholm-based impact VC fund investing in start-ups solving the world's biggest problems while building massive businesses

Sectors (2)

02 · Recent publicly announced deals

Sava Technologies 🇬🇧 Series B · Oct 2026 · $36M First-cheque stage announcement ↗

Wearable microsensors for continuous glucose and biomarker monitoring

Founders: Rafaël M., Renato C.
1Komma5 🇩🇪 Round · Oct 2026 · €70M announcement ↗ site ↗

Climate-tech unicorn selling home energy systems and its Heartbeat AI energy platform.

Founders: Philipp S., Philip L., Micha G., Jannik S.
1KOMMA5° 🇩🇪 Round · Oct 2026 site ↗

The main product of the company involves a decentralized clean energy supply system that integrates technologies such as photovoltaics, electricity storage, charging infrastructure, and heat pumps, aimed at facilitating a CO2-free lifestyle. This system is managed through a central IoT platform that utilizes algorithms for optimal operational management, enhancing the efficiency of energy generation and consumption.

Founders: Philipp S., Philip L., Micha G., Jannik S.
Sava 🇬🇧 Series B · Oct 2026 · €32.08M First-cheque stage announcement ↗ site ↗

Wearable sub-skin biosensor platform, starting with glucose

Founders: Rafaël M., Renato C.
Vocca 🇫🇷 Series A · Oct 2026 · $20M First-cheque stage announcement ↗ site ↗

Vocca provides an AI-driven solution for healthcare communication, automating patient calls, appointment scheduling, and reminders to enhance operational...

Founders: Eliott H., Hugo D.
Endra 🇸🇪 Series A · Jun 2026 · $73.4M total raised First-cheque stage site ↗

Platform for MEP engineers automating generation of 3D and 2D models and documentation, replacing manual tasks like device placement.

Founders: David R., Anton J., Niklas L., Gustav H.
Biorce 🇪🇸 Series A · Feb 2026 · $61.6M total raised First-cheque stage site ↗

AI platform streamlining the clinical trial lifecycle: protocol design, feasibility, patient identification and regulatory submissions.

Founders: Clara B., Diogo P., Pedro C.
Oviva 🇨🇭 Series D · Jan 2026 · $348.9M total raised site ↗

Personalized dietary advice via a digital app supporting targeted dietary changes for people with weight-related conditions.

Founders: Manuel B., Kai E.

03 · Similar firms

Raising? See which European funds fit your round →